{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:15:43Z","timestamp":1787498143037,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T00:00:00Z","timestamp":1517961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["ARC-LP160100427"],"award-info":[{"award-number":["ARC-LP160100427"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004365","name":"Sydney Medical School","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11095-018-2350-4","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T11:48:51Z","timestamp":1518004131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection"],"prefix":"10.1007","volume":"35","author":[{"given":"Ching-Yee","family":"Loo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing-Hin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Lauretani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santo","family":"Scalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cipolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-1551","authenticated-orcid":false,"given":"Hui Xin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,7]]},"reference":[{"key":"2350_CR1","unstructured":"Organization WH. WHO: The top 10 causes of death. 2014 [Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs310\/en\/ ."},{"issue":"11","key":"2350_CR2","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0169-409X(02)00152-7","volume":"54","author":"DJ Hassett","year":"2002","unstructured":"Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, et al. Anaerobic metabolism and quorum sensing by Pseudomonas Aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv Drug Deliv Rev. 2002;54(11):1425\u201343.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"2350_CR3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non\u2013cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"22","key":"2350_CR4","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMra0800353","volume":"359","author":"S Sethi","year":"2008","unstructured":"Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355\u201365.","journal-title":"N Engl J Med"},{"issue":"6","key":"2350_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ppul.21011","volume":"44","author":"T Bjarnsholt","year":"2009","unstructured":"Bjarnsholt T, Jensen P\u00d8, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, et al. Pseudomonas Aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol. 2009;44(6):547\u201358.","journal-title":"Pediatr Pulmonol"},{"key":"2350_CR6","doi-asserted-by":"publisher","unstructured":"Clancy J, Dupont L, Konstan M, Billings J, Fustik S, Goss C, et al. Phase II studies of nebulised Arikace in CF patients with Pseudomonas Aeruginosa infection. Thorax. 2013; 68(9): 818-825.\u00a0 https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202230 .","DOI":"10.1136\/thoraxjnl-2012-202230"},{"issue":"11","key":"2350_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1164\/rccm.201008-1293OC","volume":"183","author":"DE Geller","year":"2011","unstructured":"Geller DE, Flume PA, Staab D, Fischer R, Loutit JS, Conrad DJ. Levofloxacin inhalation solution (MP-376) in patients with cystic fibrosis with Pseudomonas Aeruginosa. Am J Respir Crit Care Med. 2011;183(11):1510\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2350_CR8","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/thoraxjnl-2013-203207","volume":"68","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Bilton D, De Soyza A, Thompson PJ, Kolbe J, Greville HW, et al. Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial. Thorax. 2013;68(9):812\u20137.","journal-title":"Thorax"},{"issue":"3","key":"2350_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1172\/JCI0213870","volume":"109","author":"D Worlitzsch","year":"2002","unstructured":"Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, et al. Effects of reduced mucus oxygen concentration in airway pseudomonas infections of cystic fibrosis patients. J Clin Invest. 2002;109(3):317\u201325.","journal-title":"J Clin Invest"},{"issue":"3","key":"2350_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.3390\/pathogens3030680","volume":"3","author":"AM Sousa","year":"2014","unstructured":"Sousa AM, Pereira MO. Pseudomonas Aeruginosa diversification during infection development in cystic fibrosis lungs\u2014a review. Pathogens. 2014;3(3):680\u2013703.","journal-title":"Pathogens"},{"issue":"3","key":"2350_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/MMBR.00013-14","volume":"78","author":"D Lebeaux","year":"2014","unstructured":"Lebeaux D, Ghigo J-M, Beloin C. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev. 2014;78(3):510\u201343.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"7346","key":"2350_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10069","volume":"473","author":"KR Allison","year":"2011","unstructured":"Allison KR, Brynildsen MP, Collins JJ. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 2011;473(7346):216.","journal-title":"Nature"},{"issue":"12","key":"2350_CR13","doi-asserted-by":"publisher","first-page":"e84220","DOI":"10.1371\/journal.pone.0084220","volume":"8","author":"N Barraud","year":"2013","unstructured":"Barraud N, Buson A, Jarolimek W, Rice SA. Mannitol enhances antibiotic sensitivity of persister bacteria in Pseudomonas Aeruginosa biofilms. PLoS One. 2013;8(12):e84220.","journal-title":"PLoS One"},{"issue":"2","key":"2350_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3390\/pathogens2020288","volume":"2","author":"D Lebeaux","year":"2013","unstructured":"Lebeaux D, Chauhan A, Rendueles O, Beloin C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens. 2013;2(2):288\u2013356.","journal-title":"Pathogens"},{"issue":"9","key":"2350_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/08927014.2012.726352","volume":"28","author":"L Santopolo","year":"2012","unstructured":"Santopolo L, Marchi E, Frediani L, Decorosi F, Viti C, Giovannetti L. A novel approach combining the Calgary biofilm device and phenotype MicroArray for the characterization of the chemical sensitivity of bacterial biofilms. Biofouling. 2012;28(9):1023\u201332.","journal-title":"Biofouling"},{"issue":"2","key":"2350_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mimet.2010.08.018","volume":"83","author":"T Coenye","year":"2010","unstructured":"Coenye T, Nelis HJ. In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods. 2010;83(2):89\u2013105.","journal-title":"J Microbiol Methods"},{"issue":"3","key":"2350_CR17","doi-asserted-by":"publisher","DOI":"10.1088\/1367-2630\/17\/3\/033017","volume":"17","author":"Y-W Chang","year":"2015","unstructured":"Chang Y-W, Fragkopoulos AA, Marquez SM, Kim HD, Angelini TE, Fern\u00e1ndez-Nieves A. Biofilm formation in geometries with different surface curvature and oxygen availability. New J Phys. 2015;17(3):033017.","journal-title":"New J Phys"},{"issue":"2","key":"2350_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejpb.2008.09.006","volume":"71","author":"CI Grainger","year":"2009","unstructured":"Grainger CI, Greenwell LL, Martin GP, Forbes B. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. Eur J Pharm Biopharm. 2009;71(2):318\u201324.","journal-title":"Eur J Pharm Biopharm"},{"key":"2350_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejpb.2015.04.012","volume":"93","author":"HX Ong","year":"2015","unstructured":"Ong HX, Traini D, Loo C-Y, Sarkissian L, Lauretani G, Scalia S, et al. Is the cellular uptake of respiratory aerosols delivered from different devices equivalent? Eur J Pharm Biopharm. 2015;93:320\u20137.","journal-title":"Eur J Pharm Biopharm"},{"issue":"12","key":"2350_CR20","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s11095-012-0827-0","volume":"29","author":"HX Ong","year":"2012","unstructured":"Ong HX, Traini D, Cipolla D, Gonda I, Bebawy M, Agus H, et al. Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia. Pharm Res. 2012;29(12):3335\u201346.","journal-title":"Pharm Res"},{"issue":"2","key":"2350_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/10837450903511194","volume":"16","author":"ME Abdelrahim","year":"2011","unstructured":"Abdelrahim ME. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade impactor compared to the next generation impactor. Pharm Dev Technol. 2011;16(2):137\u201345.","journal-title":"Pharm Dev Technol"},{"key":"2350_CR22","doi-asserted-by":"publisher","unstructured":"Haghi M, Traini D, Young P. In Vitro Cell Integrated Impactor Deposition Methodology for the Study of Aerodynamically Relevant Size Fractions from Commercial Pressurised Metered Dose Inhalers. Pharm Res. 2014;31(7):1779-87. https:\/\/doi.org\/10.1007\/s11095-013-1282-2 .","DOI":"10.1007\/s11095-013-1282-2"},{"issue":"9","key":"2350_CR23","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s11095-011-0462-1","volume":"28","author":"HX Ong","year":"2011","unstructured":"Ong HX, Traini D, Bebawy M, Young PM. Epithelial profiling of antibiotic controlled release respiratory formulations. Pharm Res. 2011;28(9):2327\u201338.","journal-title":"Pharm Res"},{"issue":"8","key":"2350_CR24","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1021\/mp400030n","volume":"10","author":"HX Ong","year":"2013","unstructured":"Ong HX, Traini D, Salama R, Anderson SD, Daviskas E, Young PM. The effects of mannitol on the transport of ciprofloxacin across respiratory epithelia. Mol Pharm. 2013;10(8):2915\u201324.","journal-title":"Mol Pharm"},{"issue":"2","key":"2350_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1208\/s12248-014-9560-4","volume":"16","author":"HX Ong","year":"2014","unstructured":"Ong HX, Traini D, Ballerin G, Morgan L, Buddle L, Scalia S, et al. Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases. AAPS J. 2014;16(2):269\u201380.","journal-title":"AAPS J"},{"issue":"8","key":"2350_CR26","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/nprot.2015.067","volume":"10","author":"SL Chua","year":"2015","unstructured":"Chua SL, Hultqvist LD, Yuan M, Rybtke M, Nielsen TE, Givskov M, et al. In vitro and in vivo generation and characterization of Pseudomonas Aeruginosa biofilm-dispersed cells via c-di-GMP manipulation. Nat Protoc. 2015;10(8):1165\u201380.","journal-title":"Nat Protoc"},{"key":"2350_CR27","unstructured":"Administration FaD. Guidance for industry; dissolution testing of immediate release solid oral dosage forms. extended release solid oral dosage forms: development, evaluation and application of in vitro\/in vivo correlations 1997."},{"issue":"6","key":"2350_CR28","first-page":"64","volume":"20","author":"JW Moore","year":"1996","unstructured":"Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996;20(6):64\u201374.","journal-title":"Pharm Technol"},{"key":"2350_CR29","unstructured":"Administration FaD. Guidance for industry; bioavailability and bioequivalence studies for orally administered drug products\u2014general considerations 2000."},{"key":"2350_CR30","doi-asserted-by":"publisher","first-page":"1):1","DOI":"10.1016\/j.ijpharm.2010.12.040","volume":"406","author":"TC Carvalho","year":"2011","unstructured":"Carvalho TC, Peters JI, Williams RO. Influence of particle size on regional lung deposition\u2013what evidence is there? Int J Pharm. 2011;406:1):1\u201310.","journal-title":"Int J Pharm"},{"issue":"Suppl 2","key":"2350_CR31","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1136\/thx.52.2008.S31","volume":"52","author":"C O'Callaghan","year":"1997","unstructured":"O'Callaghan C, Barry PW. The science of nebulised drug delivery. Thorax. 1997;52(Suppl 2):S31.","journal-title":"Thorax"},{"issue":"2","key":"2350_CR32","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1378\/chest.110.2.498","volume":"110","author":"D Hess","year":"1996","unstructured":"Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance: effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110(2):498\u2013505.","journal-title":"Chest"},{"issue":"1","key":"2350_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0378-5173(94)00255-4","volume":"115","author":"AR Clark","year":"1995","unstructured":"Clark AR. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers. Int J Pharm. 1995;115(1):69\u201378.","journal-title":"Int J Pharm"},{"issue":"3","key":"2350_CR34","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jam.2005.18.311","volume":"18","author":"J Ziegler","year":"2005","unstructured":"Ziegler J, Wachtel H. Comparison of cascade impaction and laser diffraction for particle size distribution measurements. J Aerosol Med. 2005;18(3):311\u201324.","journal-title":"J Aerosol Med"},{"issue":"6","key":"2350_CR35","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1128\/AAC.00306-13","volume":"57","author":"HX Ong","year":"2013","unstructured":"Ong HX, Traini D, Bebawy M, Young PM. Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model. Antimicrob Agents Chemother. 2013;57(6):2535\u201340.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2350_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/pharmaceutics8010006","volume":"8","author":"D Cipolla","year":"2016","unstructured":"Cipolla D, Blanchard J, Gonda I. Development of liposomal ciprofloxacin to treat lung infections. Pharmaceutics. 2016;8(1):6.","journal-title":"Pharmaceutics"},{"issue":"2","key":"2350_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI117397","volume":"94","author":"NJ Willumsen","year":"1994","unstructured":"Willumsen NJ, Davis CW, Boucher RC. Selective response of human airway epithelia to luminal but not serosal solution hypertonicity. Possible role for proximal airway epithelia as an osmolality transducer. J Clin Investig. 1994;94(2):779.","journal-title":"J Clin Investig"},{"issue":"10","key":"2350_CR38","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","volume":"15","author":"BS Tseng","year":"2013","unstructured":"Tseng BS, Zhang W, Harrison JJ, Quach TP, Song JL, Penterman J, et al. The extracellular matrix protects pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol. 2013;15(10):2865\u201378.","journal-title":"Environ Microbiol"},{"issue":"2","key":"2350_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrmicro821","volume":"2","author":"L Hall-Stoodley","year":"2004","unstructured":"Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95\u2013108.","journal-title":"Nat Rev Microbiol"},{"key":"2350_CR40","first-page":"58","volume":"13","author":"LA Cotton","year":"2009","unstructured":"Cotton LA, Graham RJ, Lee RJ. The role of alginate in P. aeruginosa PAO1 biofilm structural resistance to gentamicin and ciprofloxacin. J Exp Microbiol Immunol. 2009;13:58\u201362.","journal-title":"J Exp Microbiol Immunol"},{"issue":"9","key":"2350_CR41","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1128\/AAC.38.9.2125","volume":"38","author":"P Suci","year":"1994","unstructured":"Suci P, Mittelman M, Yu F, Geesey G. Investigation of ciprofloxacin penetration into Pseudomonas Aeruginosa biofilms. Antimicrob Agents Chemother. 1994;38(9):2125\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6058","key":"2350_CR42","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1126\/science.1211037","volume":"334","author":"D Nguyen","year":"2011","unstructured":"Nguyen D, Joshi-Datar A, Lepine F, Bauerle E, Olakanmi O, Beer K, et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science. 2011;334(6058):982\u20136.","journal-title":"Science"},{"issue":"1","key":"2350_CR43","doi-asserted-by":"publisher","first-page":"e1003144","DOI":"10.1371\/journal.pgen.1003144","volume":"9","author":"SP Bernier","year":"2013","unstructured":"Bernier SP, Lebeaux D, DeFrancesco AS, Valomon A, Soubigou G, Copp\u00e9e J-Y, et al. Starvation, together with the SOS response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet. 2013;9(1):e1003144.","journal-title":"PLoS Genet"},{"issue":"5","key":"2350_CR44","doi-asserted-by":"publisher","first-page":"L352","DOI":"10.1152\/ajplung.00387.2012","volume":"305","author":"I Bucior","year":"2013","unstructured":"Bucior I, Abbott J, Song Y, Matthay MA, Engel JN. Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas Aeruginosa pneumonia. Am J Physiol Lung Cell Mol Physiol. 2013;305(5):L352\u201363.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"2350_CR45","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrmicro2415","volume":"8","author":"H-C Flemming","year":"2010","unstructured":"Flemming H-C, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623.","journal-title":"Nat Rev Microbiol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2350-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T21:29:27Z","timestamp":1719782967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,7]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2350"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2350-4","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,7]]},"assertion":[{"value":"17 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"50"}}